Risk Factors and Timing of Native Kidney Biopsy Complications

by Marie-Christine Simard-Meilleur, Stéphan Troyanov, Louise Roy, Etienne Dalaire, Soumeya Brachemi
Published 2014-03-01

Clinical Use of Complement, Inflammation, and Fibrosis Biomarkers in Autoimmune Glomerulonephritis

by Myriam Khalili, Arnaud Bonnefoy, Dominique S. Genest, Jérémy Quadri, Jean-Philippe Rioux, Stéphan Troyanov
Published 2020-10-01

Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy

by Karyne Pelletier, Arnaud Bonnefoy, Hugo Chapdelaine, Vincent Pichette, Matthieu Lejars, François Madore, Soumeya Brachemi, Stéphan Troyanov
Published 2019-06-01

Diagnosis and outcomes of acute kidney injury using surrogate and imputation methods for missing preadmission creatinine values

by Amélie Bernier-Jean, William Beaubien-Souligny, Rémi Goupil, François Madore, François Paquette, Stéphan Troyanov, Josée Bouchard
Published 2017-04-01

Estimating the Change in Renal Function During the First Year of Therapy in ANCA-Associated Vasculitis

by Fanny Lepeytre, Virginie Royal, Pierre-Luc Lavoie, Guillaume Bollée, François Gougeon, Stéphanie Beauchemin, Maxime Rhéaume, Soumeya Brachemi, Louis-Philippe Laurin, Stéphan Troyanov
Published 2019-04-01

Activated Alpha 2-Macroglobulin Is a Novel Mediator of Mesangial Cell Profibrotic Signaling in Diabetic Kidney Disease

by Jackie Trink, Renzhong Li, Yaseelan Palarasah, Stéphan Troyanov, Thomas E. Andersen, Johannes J. Sidelmann, Mark D. Inman, Salvatore V. Pizzo, Bo Gao, Joan C. Krepinsky
Published 2021-08-01